OPTIMIZE: A phase II study of reduced dose post transplantation cyclophosphamide as GVHD prophylaxis in adult patients with hematologic malignancies receiving HLA-mismatched unrelated donor peripheral blood stem cell transplantation Meeting Abstract
| Authors: | Auletta, J. J.; Devine, S. M.; Stefanski, H. E.; Spellman, S. R.; Defor, T. E.; Logan, B. R.; Butler, B. J.; Gooptu, M.; Shaffer, B. C.; Jimenez, A. M. J.; Abedin, S.; Modi, D.; Al Malki, M. M.; Cook, R. J. |
| Abstract Title: | OPTIMIZE: A phase II study of reduced dose post transplantation cyclophosphamide as GVHD prophylaxis in adult patients with hematologic malignancies receiving HLA-mismatched unrelated donor peripheral blood stem cell transplantation |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 35141 |
| Language: | English |
| ACCESSION: | WOS:001412674000050 |
| DOI: | 10.1182/blood-2024-198252 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
